New rapid acting meal time Insulin to treat Type 2 Diabetes

Study Closed

Type of Study:

Adult Type 2

Title of Study:

A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro, Both in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 2 Diabetes PRONTO-T2D

Short Title:

New rapid acting meal time Insulin to treat Type 2 Diabetes

Study Length: 39 Weeks

Target Age/Sex: 18+, Male and Female

Benefits:

Participants will receive at no cost: Study medication, study related supplies, study related lab work and medical exams. Subject will also receive a stipend for time/travel related to the study.

Link: ClinicalTrials.gov

Live better, healthier, smarter

Schedule an Appointment